The dissolution studies of both formulations were conducted using USP apparatus @ at @ rpm with @ mL of phosphate buffer solution ( pH , @ ) at @C @ C. Bioequivalence was defined per Korean Food and Drug Administration 's regulatory criteria as @ % CIs of the geometric mean test/reference ratios of AUC@-t and Cmax within the range of @ to @ .